The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: IDE CFO departs; Griffin hires former Dignity chair

Thu, 12th Aug 2021 12:58

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and not separately reported by Alliance News:

----------

IDE Group Holdings PLC - Edinburgh-based network, cloud and IT managed services - Chief Financial Officer David Templeman resigns immediately, with no reason provided by company. Templeman had only joined IDE in April. He had been CFO of Orbian, a provider of supply chain finance originally set up as a joint venture between Citigroup Inc and SAP SE. IDE says it will recruit another CFO "in due course". IDE's annual general meeting is coming up on August 23. IDE shares are down 15% on Thursday at midday in London.

----------

B&M European Value Retail SA - Luxembourg-based food and homewares retailer - Hires Paula MacKenzie as non-executive director, starting November 9. MacKenzie was managing director for fast-food chain Kentucky Fried Chicken in the UK and Ireland and before that CFO for the region. She also has worked for drug maker GlaxoSmithKline PLC and distiller Diageo PLC.

----------

Norman Broadbent PLC - London-based recruitment - Angela Hickmore moves to non-executive director, starting Thursday. Hickmore currently is the company's managing director, having joined Norman Broadbent in 2016. The company is looking for a new chief executive officer, and once one is found, Hickmore will hand over her executive responsibilities, it explains. Last month, Mike Brennan resigned as CEO after five years at the company. Peter Searle remains executive chair.

----------

Griffin Mining Ltd - operator of the Caijiaying zinc-gold mine in China - Appoints Clive Whiley as senior independent director. Notes Whiley has more than 35 years experience as an executive and as a non-executive director, including business experience in China. Whiley was chair of funeral services provider Dignity PLC until ousted in a general meeting vote in April called by major shareholder Phoenix Asset Management Partners.

----------

Eleco PLC - London-based construction software - Executive Chair Serena Lang will return to non-executive chair role in September. Kevin Craig and David Dannhauser both will step down from the board at the end of August, while Anders Karlsson will step down as an executive director but remain managing director for Nordics. Eleco hires two new independent non-executive directors. Annette Nabavi joins the board immediately. Nabavi, who will replace Craig as senior independent director, was a non-executive director of AIM-listed cloud services firm Maintel Holdings PLC. She is managing director of Anchusa Consulting and partner at AHV Associates, advising on corporate finance in both roles. Mark Castle joins on September 20. Castle is a non-executive director of Mace Group and previously was the construction and facilities management firm's chief operating officer.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.